Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome
NCT00385099 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2017-08-08
Summary
The purpose of this study is to see if GW876008 in Irritable Bowel Syndrome patients will reverse stress-induced hypersensitivity, by looking at thresholds for perception and pain.
Conditions
- Irritable Colon
Interventions
- DRUG
-
GW876008
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-08
- Primary Completion
- 2007-10-15
- Completion
- 2007-10-15
Countries
- United Kingdom
Study Locations
More Related Trials
-
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
NCT00584298 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of BMS-562086 in Patients With Irritable Bowel Syndrome
NCT00399438 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome
NCT00135031 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects
NCT02798991 ·Status: COMPLETED ·Phase: PHASE1
-
Diarrhea Predominant Irritable Bowel Syndrome in Females
NCT00461526 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers
NCT02727283 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)
NCT00268879 ·Status: COMPLETED ·Phase: PHASE3
-
Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)
NCT00101985 ·Status: COMPLETED ·Phase: PHASE2
-
Proof-of-Principle Study of TC-6499 in the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS)
NCT01149200 ·Status: COMPLETED ·Phase: PHASE2
-
A 14-week Pilot Prospective Clinical Trial With BiOkuris Product in Patients With Irritable Bowel Syndrome
NCT05780749 ·Status: COMPLETED ·Phase: NA
-
A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers
NCT03154086 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
NCT00699166 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
NCT00394173 ·Status: COMPLETED ·Phase: PHASE2
-
Genetic Carbohydrate Maldigestion as a Model to Study Food Hypersensitivity
NCT05795049 ·Status: ACTIVE_NOT_RECRUITING
-
Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)
NCT00610909 ·Status: COMPLETED ·Phase: PHASE4
-
Ethosuximide to Treat IBS
NCT02973542 ·Status: COMPLETED ·Phase: PHASE2
-
Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)
NCT00761007 ·Status: COMPLETED ·Phase: PHASE2
-
Manipulation of Visceral Sensitivity and Immune System in IBS
NCT00418340 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel Syndrome
NCT02079675 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome
NCT02108119 ·Status: COMPLETED ·Phase: PHASE2
-
Gastrointestinal Symptoms in Healthy Subjects and Patients With Irritable Bowel Syndrome
NCT01457378 ·Status: COMPLETED
-
A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.
NCT00139672 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
NCT01844180 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
NCT03977155 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
NCT03573908 ·Status: COMPLETED ·Phase: PHASE3